<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>IgG antibodies to nuclear lamin proteins have been found in serum samples from 31 patients using immunofluorescence on HEp-2 cells, Western blotting, and enzyme-linked immunosorbent assay, performed against a nuclear lamina preparation from Ehrlich <z:hpo ids='HP_0001541'>ascites</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Antilamin antibodies were most prevalent among patients with nonerosive, <z:e sem="disease" ids="C0409679" disease_type="Disease or Syndrome" abbrv="">seronegative polyarthritis</z:e>, or patients showing serum antiphospholipid reactivity as well </plain></SENT>
<SENT sid="2" pm="."><plain>It is possible that anti-lamin antibodies may thus be a marker for a subgroup of <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> patients who have a different prognosis from that of those with seropositive <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The mechanism for the combined occurrence of anti-lamin and antiphospholipid autoantibodies is obscure </plain></SENT>
<SENT sid="4" pm="."><plain>Future studies will answer whether these two antibodies represent a distinct antibody profile in patients with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
</text></document>